Breaking News Instant updates and real-time market news.

GNC

GNC Holdings

$19.40

-0.36 (-1.82%)

, BANC

Banc of California

$11.26

-4.61 (-29.05%)

09:06
10/19/16
10/19
09:06
10/19/16
09:06

On The Fly: Pre-market Movers

HIGHER: Banc of California (BANC), up 16% after reporting better than expected Q3 earnings, raising its FY16 EPS outlook and demanding the removal and retraction of a Seeking Alpha article that the bank's lawyers call "inaccurate" and "malicious"... GNC Holdings (GNC), up 5% after The Wall Street Journal reported that the company has recently met with potential Chinese buyers to gauge their interest in a buyout that could be worth $4B including debt... ServiceNow (NOW) is up 3% and Tableau Software (DATA) is up 5% after The Wall Street Journal reported that both companies were included on a list of 14 potential acquisition targets that were named in a presentation included in leaked emails from a member of Salesforce's (CRM) board of directors. DOWN AFTER EARNINGS: Intel (INTC), down 4.5%... Cree (CREE), down 10.7%. ALSO LOWER: Imperva (IMPV), down 16% after Bloomberg reported that the company's sales process is on hold as Imperva seeks a higher price... Rite Aid (RAD), down 5% after the New York Post said that Kroger (KR) intends to pass on buying the 650 stores that Walgreens (WBA) would have to sell to gain regulatory approval for its planned Rite Aid merger.

GNC

GNC Holdings

$19.40

-0.36 (-1.82%)

BANC

Banc of California

$11.26

-4.61 (-29.05%)

DATA

Tableau

$47.23

0.03 (0.06%)

NOW

ServiceNow

$76.16

1.52 (2.04%)

CRM

Salesforce

$72.77

-0.06 (-0.08%)

IMPV

Imperva

$46.65

-0.25 (-0.53%)

INTC

Intel

$37.75

0.46 (1.23%)

CREE

Cree

$25.20

0.4 (1.61%)

RAD

Rite Aid

$7.02

-0.02 (-0.28%)

WBA

Walgreens Boots Alliance

$78.08

0.07 (0.09%)

KR

Kroger

$30.64

-0.19 (-0.62%)

  • 19

    Oct

  • 20

    Oct

  • 26

    Oct

  • 27

    Oct

  • 03

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 09

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 16

    Nov

  • 08

    Dec

  • 12

    Dec

GNC GNC Holdings
$19.40

-0.36 (-1.82%)

09/23/16
LEHM
09/23/16
INITIATION
Target $21
LEHM
Equal Weight
GNC Holdings initiated with an Equal Weight at Barclays
Barclays analyst Karen Short started GNC Holdings with an Equal Weight rating and $21 price target.
08/01/16
08/01/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Royal Dutch Shell (RDS.A) downgraded to Sector Perform from Outperform at RBC Capital with analyst Biraj Borkhataria citing valuation and the company's debt burden. 2. Dollar General (DG) downgraded to Hold from Buy at Deutsche Bank with analyst Paul Trussell citing valuation. 3. Harley-Davidson (HOG) downgraded to Underweight from Equal Weight at Barclays with analyst Felicia Hendrix saying she sees "no clear catalyst" for when the company's challenges may subside. 4. GNC Holdings (GNC) downgraded to Neutral from Outperform at Wedbush with analyst Phil Terpotilli saying he believes that the company has weak comp trends and sees limited visibility into strategic alternatives. 5. Ford (F) downgraded to Underperform from Neutral at Daiwa. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/01/16
WEDB
08/01/16
DOWNGRADE
WEDB
Neutral
GNC Holdings downgraded on lack of catalysts, sales outlook at Wedbush
As noted earlier, Wedbush downgraded GNC Holdings to Neutral from Outperform. Analyst Phil Terpotilli believes that the company has weak comp trends and sees limited visibility into strategic alternatives. He thinks that the company lacks near-term catalysts and cut his price target on the shares to $23 from $31.
08/01/16
WEDB
08/01/16
DOWNGRADE
WEDB
Neutral
GNC Holdings downgraded to Neutral from Outperform at Wedbush
BANC Banc of California
$11.26

-4.61 (-29.05%)

10/18/16
RAJA
10/18/16
NO CHANGE
RAJA
Outperform
Raymond James advises to 'consider the source' of Banc of California short call
Raymond James noted that Aurelius, the source of a short report that has been attributed as the source of weakness in shares of Banc of California, has previously authored several short pieces that contained "highly speculative conclusions" that have proven incorrect. The firm has an Outperform rating on Banc of California shares.
08/17/16
FIGP
08/17/16
DOWNGRADE
FIGP
Underperform
Banc of California downgraded to Underperform at Fig Partners
Fig Partners downgraded Banc of California to Underperform from Market Perform.
10/19/16
UBSW
10/19/16
NO CHANGE
UBSW
UBS places Banc of California rating under review
UBS analyst David Eads placed his Buy rating and $28 price target on shares of Banc of California under review after an "anonymous report posted on Seeking Alpha" discussed ties between the company's board and a convicted felon. Banc of California issued a press release last night but is yet to fully address the concerns raised in the report, Eads tells investors in a research note. He believes management needs to provide a "thorough disclosure" of their ties to the individual when reporting earnings on Thursday morning. Eads wants more clarity before reinstating his rating on the stock. Banc of California closed yesterday down 29% to $11.26.
10/19/16
WELS
10/19/16
NO CHANGE
WELS
Outperform
Wells recommends owning Banc of California into Thursday's results
With the stock down 29% yesterday and nearly 50% in two months, "the damage has been done at this point," Wells Fargo analyst Timur Braziler tells investors in a research note. He recommends staying long the shares into Thursday's earnings report, expecting it will be a good one. Braziler looks for a more detailed explanation on the earnings call regarding the company's ties with Jason Galanis, which a short report detailed yesterday. The analyst keeps an Outperform rating on Banc of California shares with a $23-$25 price target range. UBS this morning placed its Buy rating on the stock under review.
DATA Tableau
$47.23

0.03 (0.06%)

08/25/16
RBCM
08/25/16
DOWNGRADE
RBCM
Sector Perform
Tableau downgraded on cloud transition, competition at RBC Capital
As noted earlier, RBC Capital downgraded Tableau to Sector Perform from Outperform. As reasons for the downgrade, analyst Matthew Hedberg cited the company's transition to the cloud and increased competition. Additionally, the analyst believes that a takeover has become less likely after the company named a new CEO. Target $65.
09/30/16
COWN
09/30/16
NO CHANGE
COWN
Hortonworks checks 'concerning,' quarter at risk, says Cowen
Cowen analyst J. Derrick Wood said his checks suggest there have been many high-level employee departures at Hortonworks (HDP) and he also thinks that sales productivity is constrained, presenting risk to its quarterly results. Meanwhile, he said that his checks on Teradata (TDC) remain constructive, noting that he is hearing the company is already signing orders for cloud with its core analytical database products now available on AWS. There are "some encouraging data points" for Tableau (DATA), said Wood, who added that he still has more field work to do around its quarter.
09/14/16
OPCO
09/14/16
NO CHANGE
Target $62
OPCO
Outperform
Oppenheimer remains positive on Tableau long-term opportunity
Oppenheimer analyst Ittai Kidron says he remains positive on Tableau's long-term opportunity after meeting with the company's management, but notes that investors may need to build in a multiple-quarter view. He says the key is execution and recommends buying ahead of proof points given the size of the BI/Analytics opportunity and ongoing signs of Tableau's differentiation. Kidron reiterates an Outperform rating and $62 price target on the shares.
08/25/16
RBCM
08/25/16
DOWNGRADE
RBCM
Sector Perform
Tableau downgraded to Sector Perform from Outperform at RBC Capital
NOW ServiceNow
$76.16

1.52 (2.04%)

09/19/16
BMOC
09/19/16
INITIATION
BMOC
Market Perform
ServiceNow initiated with a Market Perform at BMO Capital
10/12/16
OTRG
10/12/16
DOWNGRADE
OTRG
Mixed
ServiceNow downgraded to Mixed from Positive at OTR Global
10/18/16
PIPR
10/18/16
NO CHANGE
Target $90
PIPR
Overweight
Piper sees ServiceNow Q3 earnings report as catalyst
Piper Jaffray analyst Alex Zukin says his recent conversations with industry partners indicate "strong" renewal and net new business in ServiceNow's (NOW) Q3. He expects the company to outperform consensus expectations. Zukin sees the earnings report as a catalyst and points out that shares of ServiceNow are down 12% year-to-date while trading at a 14% discount to Workday (WDAY). The analyst reiterates an Overweight rating on ServiceNow with a $90 price target.
09/15/16
GUGG
09/15/16
INITIATION
Target $90
GUGG
Buy
ServiceNow initiated with a Buy at Guggenheim
Guggenheim analyst Ryan Hutchinson initiated ServiceNow with a Buy and a $90 price target.
CRM Salesforce
$72.77

-0.06 (-0.08%)

10/07/16
ADAM
10/07/16
NO CHANGE
Target $95
ADAM
Buy
Salesforce worthy of investor consideration at current levels, says Canaccord
Canaccord analyst Richard Davis came away from the Salesforce (CRM) Dreamforce week more enthused about the company's outlook. The analyst noted the company is growing its revenues 3.5 times faster than it legacy peers. Davis noted the company's CEO said they are very disciplined on price when it comes to acquisitions and believes that they would not be interested in Twitter (TWTR) at its rumored asking price of $28 per share. Davis reiterated his Buy rating and $95 price target on Salesforce shares.
10/10/16
JPMS
10/10/16
NO CHANGE
Target $95
JPMS
Overweight
JPMorgan sees 'opportune entry point' for Salesforce
JPMorgan analyst Mark Murphy believes shares of Salesforce (CRM) are at an "'opportune entry point" following the recent selloff. The pullback has been driven by a "slightly soft" Q2 and concerns about a potentially expensive acquisition of Twitter (TWTR), Murphy tells investors in a research note. After speaking to industry contacts at Dreamforce, the analyst sees a path for the "overhangs to fade" with a "better pace of business in Q3/Q4" as well as the eventual fading of the Twitter discussion. Murphy reiterates an Overweight rating on Salesforce with a $95 price target in a research note titled "The Most Valuable Cloud Asset Is Undeservedly Undervalued."
10/14/16
RAJA
10/14/16
NO CHANGE
RAJA
Raymond James said Salesforce not bidding for Twitter a significant positive
Raymond James said reports Salesforce (CRM) will not bid for Twitter (TWTR) is a significant positive for shares and could set the stage for a sustained stock recovery and breakout in the stock.
10/18/16
RSBL
10/18/16
INITIATION
Target $90
RSBL
Buy
Salesforce initiated with a Buy at Rosenblatt
Rosenblatt analyst Marshall Senk initiated Salesforce.com with a Buy and a $90 price target. The analyst believes Q2 weakness will prove to be a short-term issue and said the company is rebounding strongly here in Q3 and is setup well for the fourth quarter. Further, he has confidence in FY18 sales of $10B driven by customer adoption, as supported by the balance sheet.
IMPV Imperva
$46.65

-0.25 (-0.53%)

10/03/16
BTIG
10/03/16
DOWNGRADE
BTIG
Neutral
Imperva downgraded to Neutral from Buy at BTIG
BTIG analyst Joel Fishbein downgraded Imperva to Neutral saying valuation reflects a potential acquisition of the company.
10/06/16
DADA
10/06/16
DOWNGRADE
DADA
Neutral
Imperva downgraded to Neutral from Buy at DA Davidson
10/06/16
DADA
10/06/16
DOWNGRADE
DADA
Neutral
Imperva downgraded on valuation at DA Davidson
As noted earlier, DA Davidson downgraded Imperva to Neutral from Buy. Analyst Jack Andrews downgraded the stock based on valuation. He thinks that a number of strategic and financial entities could be interested in buying Imperva, and he believes that the company will probably be sold "over the next few months." However, the analyst thinks that the company may not be bought for a price that is significantly higher than its current valuation. Target remains $55.
10/19/16
JPMS
10/19/16
NO CHANGE
JPMS
Neutral
Imperva needs consistent performance to regain footing, says JPMorgan
After the Wall Street Journal reported that Imperva put its sales process on hold after the expected bidders dropped out, JPMorgan analyst Sterling Auty says the stock will need "a couple of quarters of consistent topline performance and improving margins to once again find its footing." The stock will likely see "heavy pressure" today, Auty tells investors in a research note. He keeps a Neutral rating on the shares.
INTC Intel
$37.75

0.46 (1.23%)

10/19/16
PACS
10/19/16
NO CHANGE
PACS
Intel Q4 PC commentary negative for Marvell, others resilient says Pacific Crest
Pacific Crest notes that Intel (INTC) said its PC customers are poised to reduce their inventories in Q4. The firm says that the comment is negative for Marvell (MRVL). However, the firm believes that Advanced Micro Devices (AMD), NVIDIA (NVDA), ON Semiconductor (ON) and Synaptics (SYNA) are "most resilient" to this development, given their share gains, growth and other factors.
10/19/16
ROTH
10/19/16
NO CHANGE
Target $40
ROTH
Buy
Roth Capital cuts Intel price target after guidance disappoints
Roth Capital analyst Suji Desilva lowered his price target for Intel to $40 from $43 after disappointing guidance. However, the analyst expects the shares to recover with a reset of expectations. Desilva continues to be encouraged by the company's transition to growth areas such as cloud data center, networking and IoT, and by the stable margin profile. He reiterates a Buy rating on the shares.
10/19/16
PACS
10/19/16
NO CHANGE
PACS
Intel data center results bode badly for several stocks, says Pacific Crest
Pacific Crest says that Intel's (INTC) data center results and commentary were "modestly disappointing," as enterprise demand for the company's data center products was "weak," according to the firm. The firm thinks that the negative enterprise results are "modestly negative for stocks with enterprise exposure, including Micron (MU), Seagate (STX) and Western Digital (WDC)."
10/19/16
BARD
10/19/16
NO CHANGE
Target $42
BARD
Outperform
Intel fundamentals improving despite server shortfall, says Baird
Baird analyst Tristan Gerra believes Intel will maintain its 40% market share in mobile resulting in a continued decline in its mobile losses in 2017. The analyst noted the company lowered its outlook for client data center groups, which could weigh on the shares for the remainder of the year. Gerra believes the longer-term fundamentals remain intact with a still rising DCG mix, stabilization in PC comps, and further reductions in mobile losses driving a sustainable resumption in earnings growth. Gerra reiterated his Outperform rating and $42 price target on Intel shares.
CREE Cree
$25.20

0.4 (1.61%)

10/19/16
GSCO
10/19/16
NO CHANGE
Target $17
GSCO
Sell
Cree's valuation remains rich, says Goldman
Goldman analyst Brian Lee said Cree reported a mixed Q1 and guided Q2 below his expectations. He believes LED remains a source of downside risk on pricing pressure and visibility on a recovery to double-digit sales growth remains low. Lee sees more downside risk to Cree shares given the lack of growth in both lighting and LED and reiterated his Sell rating and lowered his price target to $17 from $18 on shares.
08/25/16
08/25/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cree (CREE) initiated with a Buy at Roth Capital. 2. Reynolds American (RAI) initiated with a Neutral at UBS. 3. Twilio (TWLO) initiated with a Hold at Argus. 4. Phillips 66 Partners (PSXP) initiated with a Neutral at Goldman. 5. WD-40 (WDFC) initiated with a Hold at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/19/16
SPHN
10/19/16
DOWNGRADE
SPHN
Equal Weight
Cree downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Harsh Kumar downgraded Cree to Equal Weight from Overweight following the company's Q1 report and Q2 guidance, saying the company's execution "continues to be lacking."
09/30/16
WILL
09/30/16
INITIATION
Target $23
WILL
Hold
Cree initiated with a Hold at Williams Capital
Williams Capital analyst Cynthia Motz initiated Cree with a Hold and a $23 price target.
RAD Rite Aid
$7.02

-0.02 (-0.28%)

10/17/16
COWN
10/17/16
NO CHANGE
Target $95
COWN
Outperform
Walgreens Boots Alliance guidance may be softer than expected, says Cowen
Cowen analyst Charles Ryhee still likes the long-term story for Walgreens Boots Alliance (WBA) but said, given the pressures due to currency and brand inflation, its 2017 guidance may be softer than expected. Ryhee likes the long-term outlook based on the company's recent deals, its Rite-Aid (RAD) acquisition, and cost reductions. Ryhee maintained his Outperform rating and lowered his price target to $95 from $102 on Walgreen's shares.
07/19/16
LEER
07/19/16
NO CHANGE
Target $95
LEER
Outperform
Leerink remains positive on Walgreens Boots Alliance long-term
Leerink analyst David Larsen remains positive on Walgreens Boots Alliance (WBA) in the long-term, despite reducing his forward revenue and earnings estimates due mainly to trends in FX. Larsen still believes that the Rite Aid (RAD) deal will close in the second half of 2016, and expects shares of Walgreens Boots Alliance to rally once that happens. The analyst reiterates an Outperform rating and $95 price target on Walgreens Boots Alliance's shares.
09/01/16
FBCO
09/01/16
NO CHANGE
FBCO
Walgreens Boots Alliance added to Focus List at Credit Suisse
Credit Suisse analyst Robert Willoughby said Walgreens Boots Alliance (WBA) closing of the Rite Aid (RAD) acquisition in 2H 2016 will bring meaningful revenue growth, cash flow, and cost cutting opportunities to drive Walgreens shares higher. The analyst sees limited downside given new and potentially more preferred pharmacy network agreements with leading PBMs, capital deployment, and the early AmerisourceBergan warrant exercise. Willoughby reiterates his Outperform rating and $95 price target on Walgreens shares and the investment policy committee added it to the Credit Suisse Focus List.
10/17/16
JEFF
10/17/16
UPGRADE
Target $95
JEFF
Buy
Walgreens Boots Alliance upgraded to Buy from Hold at Jefferies
Jefferies analyst Brian Tanquilut upgraded Walgreens Boots Alliance to Buy after assuming coverage of the name. The analyst believes the risk/reward for the Rite Aid (RAD) acquisition is skewed positively at current valuation levels. He also thinks Walgreens' fundamental positives are being underappreciated by investors. Tanquilut upped his price target for the shares to $95 from $87.
WBA Walgreens Boots Alliance
$78.08

0.07 (0.09%)

10/05/16
UBSW
10/05/16
INITIATION
Target $94
UBSW
Buy
Walgreens Boots Alliance initiated with a Buy at UBS
Target $94.
10/13/16
LEER
10/13/16
NO CHANGE
Target $105
LEER
Outperform
Tricare announcement not material to CVS Health, says Leerink
Leerink analyst David Larsen notes that Tricare recently announced that CVS Health (CVS) will be excluded from its network effective December 1 and Walgreens Boots Alliance (WBA) will be in-network. While there are over 127M scripts associated with Tricare each year, the analyst estimates that just about 30.6M of these prescriptions are "retail" and as a result Larsen does not believe that CVS' exclusion from the Tricare network will be material. He remains positive on CVS, and reiterates an Outperform rating and $105 price target on the company's shares.
KR Kroger
$30.64

-0.19 (-0.62%)

09/23/16
LEHM
09/23/16
INITIATION
Target $33
LEHM
Equal Weight
Kroger initiated with an Equal Weight at Barclays
Barclays analyst Karen Short started Kroger with an Equal Weight rating and $33 price target.
10/10/16
OPCO
10/10/16
NO CHANGE
OPCO
Wal-Mart 'starting to get its act together' in grocery, says Oppenheimer
After attending Wal-Mart's (WMT) analyst day meeting, Oppenheimer analyst Rupesh Parikh admitted he did not previously look favorably upon the company's strategy to expand into Neighborhood Market and smaller format stores, but he now sees signs that the company is "starting to get its act together in grocery." If Wal-Mart follows through with grocery price investments, it could hurt Kroger (KR), Smart & Final Stores (SFS) and Supervalu (SVU) and be an "indirect negative" for Sprouts Farmers Markets (SFM), Parikh tells investors. However, he also added that he remains confident in the ability of Kroger's management team to at least hold share.
10/07/16
PIVT
10/07/16
NO CHANGE
PIVT
Whole Foods FY17 earnings risk not fully appreciated, says Pivotal Research
Pivotal Research said recent chatter involving Kroger (KR) and Whole Foods (WFM) follows a steady stream of bogus takeover rumors that seem to surface with little or no reasonable basis. The firm's analyst said this appears to be another head fake that distracts from core challenges facing Whole Foods ahead of 4Q16 results in early November and potential disappointing FY17 guidance. Pivotal said although Whole Foods multiple is not demanding, the extent of a FY17 earnings risk is not fully appreciated by the Street.
10/07/16
SBSH
10/07/16
NO CHANGE
Target $39
SBSH
Buy
Citi says Whole Foods buyout would be uncharacteristic for Kroger
Citi analyst Alvin Concepcion weighs in on the speculation yesterday that Kroger (KR) could be interested in acquiring Whole Foods (WFM) for $40 per share. There are challenges that reduce the likelihood of a deal, and such a transaction could be uncharacteristic for Kroger, Concepcion tells investors in a research note. For one, the acquisition would be expensive, the analyst contends. And two, Kroger would have to lever up to 3.5 times net debt/EBITDA, he adds. The analyst keeps a Buy rating on Kroger with a $39 price target. Whole Foods yesterday closed up 5% to $29.33 amid the takeout rumor.

TODAY'S FREE FLY STORIES

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

17:22
12/02/16
12/02
17:22
12/02/16
17:22
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

, IM

Ingram Micro

$38.88

1.31 (3.49%)

17:21
12/02/16
12/02
17:21
12/02/16
17:21
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

17:20
12/02/16
12/02
17:20
12/02/16
17:20
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:16
12/02/16
12/02
17:16
12/02/16
17:16
Periodicals
President Obama blocks China's takeover of Aixtron, CNBC reports »

Says the transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.74

-0.32 (-1.99%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Periodicals
Deutsche Bank to pay $60M settlement over gold price-fixing case, Reuters says »

Deutsche Bank will pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

ALB

Albemarle

$84.86

-0.79 (-0.92%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Hot Stocks
Albemarle to increase prices for select brominated products »

Albemarle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

FOR

Forestar Group

$13.40

0.2 (1.52%)

17:06
12/02/16
12/02
17:06
12/02/16
17:06
Hot Stocks
Breaking Hot Stocks news story on Forestar Group »

Carlson Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$108.14

-1.86 (-1.69%)

17:04
12/02/16
12/02
17:04
12/02/16
17:04
Syndicate
Breaking Syndicate news story on Diamondback Energy »

Diamondback Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSIR

Osiris

$5.68

0.06 (1.07%)

17:02
12/02/16
12/02
17:02
12/02/16
17:02
Hot Stocks
Osiris: Nasdaq grants company's request for additional time »

Osiris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STOR

STORE Capital

$24.45

0.52 (2.17%)

17:00
12/02/16
12/02
17:00
12/02/16
17:00
Hot Stocks
STORE Capital director Donovan acquires 4,350 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARB

Carbonite

$17.95

0.25 (1.41%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
Breaking Hot Stocks news story on Carbonite »

Crosslink lowers stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIB

CGI Group

$47.11

0.16 (0.34%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
CGI Group announces specific share repurchase program »

CGI Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.